Anti-Human CD3 Recombinant Antibody (TAB-159)
The antibody specifically targets the CD3 epsilon chain present on T lymphocytes. It binds to the CD3 molecule on the surface of T cells. By engaging with CD3, the mAb alters the immune response, offering potential in decelerating the progression of type 1 diabetes.
Anti-Human CD3 Recombinant Antibody (TAB-159)
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The antibody specifically targets the CD3 epsilon chain present on T lymphocytes. It binds to the CD3 molecule on the surface of T cells. By engaging with CD3, the mAb alters the immune response, offering potential in decelerating the progression of type 1 diabetes. It is designed to support reliable, reproducible results in modern laboratories. It helps streamline your workflow, reduce troubleshooting, and deliver consistent performance across batches. Prominent attributes include productname and abbr.
Manufactured under rigorous quality controls, each lot is checked for key specifications to ensure lot‑to‑lot consistency. The format is optimized for ease of use and integration into existing protocols, with documentation available upon request.
Key Features / Benefits
- productname: Anti-Human CD3E Recombinant Antibody (TAB-159)
- abbr: Anti-CD3 Antibody (TAB-159)
- Target: CD3E
- Host Animal: Mouse
- Specificity: Tested positive against native human antigen.
- Immunogen: The details of the immunogen for this antibody are not available.
Relevant Applications
- Neut
- ELISA
- IF
- IP
- FuncS
- FC
- ICC
- The CD3E antibody has been reported in applications of FC
